These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20269992)

  • 1. Detection of intravascular clotting tendency by heparin tolerance principle; methods and clinical application.
    TUFT HS; ROSENFIELD RE
    Am J Clin Pathol; 1947 Nov; 17(11):862-5. PubMed ID: 20269992
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system.
    Gaszyński W
    Anaesth Resusc Intensive Ther; 1975; 3(2):125-34. PubMed ID: 1080969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved plasma recalcified clotting test and its modification as a simple rapid heparin retarded clotting test.
    EASTHAM RD
    J Clin Pathol; 1962 Jan; 15(1):86-7. PubMed ID: 13888970
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of heparin on chronically induced intravascular coagulation in dogs.
    Owen CA; Bowie EJ
    Am J Physiol; 1975 Aug; 229(2):449-54. PubMed ID: 1163671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in blood coagulation following coronary thrombosis measured by the heparin retarded clotting test (Waugh and Ruddick test).
    OGURA JH; FETTER NR
    J Clin Invest; 1946 Jul; 25(4):586-96. PubMed ID: 21001633
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in blood coagulation following coronary thrombosis measured by the heparin retarded clotting test (Waugh and Ruddick test).
    OGURA JH; FETTER NR
    Proc Annu Meet Cent Soc Clin Res U S; 1945; 18():47. PubMed ID: 21021618
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heparin-retarded plasma clotting test.
    POLLER L
    Angiology; 1954 Feb; 5(1):21-6. PubMed ID: 13124814
    [No Abstract]   [Full Text] [Related]  

  • 9. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography.
    Gantioqui J; Stevic I; Atkinson H; Chan AKC
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):521-527. PubMed ID: 29965810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the activated clotting time in anticoagulation monitoring of intravascular procedures.
    Bowers J; Ferguson JJ
    Tex Heart Inst J; 1993; 20(4):258-63. PubMed ID: 8298321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity to Heparin of the Clotting Inhibitor in Acute Leucemia and the Significance of Hyperheparinemia in Estrapenic Cholinergic States.
    Barnard RD
    Science; 1948 May; 107(2787):571-2. PubMed ID: 17779205
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin clotting time.
    Ignjatovic V
    Methods Mol Biol; 2013; 992():131-8. PubMed ID: 23546710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of heparin on the early stages of blood coagulation.
    O'BRIEN JR
    J Clin Pathol; 1960 Mar; 13(2):93-8. PubMed ID: 14428016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aureomycin on heparin concentration and clotting time of human blood.
    WAISBREN BA; GLICK D
    J Lab Clin Med; 1950 Dec; 36(6):1001. PubMed ID: 14795098
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors of system clotting in heparin-free haemodialysis.
    Keller F; Seemann J; Preuschof L; Offermann G
    Nephrol Dial Transplant; 1990; 5(9):802-7. PubMed ID: 2129354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.